These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2263042)

  • 1. [Methods of examination of the angiogenetic activity of the retina].
    Prost M
    Klin Oczna; 1990 Aug; 92(3-4):69-71. PubMed ID: 2263042
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental studies on the angiogenic activity of the detached retina.
    Prost M
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(1):83-5. PubMed ID: 2311949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental studies of the angiogenic activity of the detached retina].
    Prost M
    Klin Oczna; 1988 Sep; 90(9):299-301. PubMed ID: 2469822
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on retinal neovascularization.
    Patz A
    Trans New Orleans Acad Ophthalmol; 1983; 31():82-8. PubMed ID: 6194596
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on retinal neovascularization. Friedenwald Lecture.
    Patz A
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1133-8. PubMed ID: 6158493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and activation of STAT3 in ischemia-induced retinopathy.
    Mechoulam H; Pierce EA
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4409-16. PubMed ID: 16303927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of adenosine A2a receptor in retinal development and oxygen-induced retinopathy.
    Taomoto M; McLeod DS; Merges C; Lutty GA
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):230-43. PubMed ID: 10634625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5' nucleotidase and adenosine during retinal vasculogenesis and oxygen-induced retinopathy.
    Lutty GA; Merges C; McLeod DS
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):218-29. PubMed ID: 10634624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunologic phenomena in patients with proliferative retinopathy in diabetes mellitus type 1].
    Pawińska M; Bak M; Sommer E; Wróblewski T; Chyzyk A
    Pol Arch Med Wewn; 1989 Apr; 81(4):240-6. PubMed ID: 2626350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of retinal vascular development and neovascularization in transgenic mice over-expressing thrombospondin-1 in the lens.
    Wu Z; Wang S; Sorenson CM; Sheibani N
    Dev Dyn; 2006 Jul; 235(7):1908-20. PubMed ID: 16691615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts.
    Wang S; Zheng Z; Weng Y; Yu Y; Zhang D; Fan W; Dai R; Hu Z
    Life Sci; 2004 Apr; 74(20):2467-78. PubMed ID: 15010258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subretinal choroidal neovascularization as a response to penetrating retinal injury in the pigmented rabbit.
    Hsu HT; Goodnight R; Ryan SJ
    Jpn J Ophthalmol; 1989; 33(3):358-66. PubMed ID: 2796014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RPE-associated extracellular matrix changes accompany retinal vascular proliferation and retino-vitreal membranes in a new model for proliferative retinopathy: the dystrophic rat.
    Caldwell RB; Slapnick SM; Roque RS
    Prog Clin Biol Res; 1989; 314():393-407. PubMed ID: 2608671
    [No Abstract]   [Full Text] [Related]  

  • 14. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
    McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The demonstration of angiogenic activity from ocular tissues. Preliminary report.
    Glaser BM; D'Amore PA; Michels RG; Brunson SK; Fenselau AH; Rice T; Patz A
    Ophthalmology; 1980 May; 87(5):440-6. PubMed ID: 6157142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oxygen tension on the quantities of procollagenase-activating angiogenic factor present in the developing kitten retina.
    Taylor CM; Weiss JB; Kissun RD; Garner A
    Br J Ophthalmol; 1986 Mar; 70(3):162-5. PubMed ID: 2420354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy.
    Franklin AJ; Jetton TL; Kuchemann CL; Russell SR; Kohn EC
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3756-66. PubMed ID: 15452087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic activity of vitreous and retinal extract.
    Chen CH; Chen SC
    Invest Ophthalmol Vis Sci; 1980 Jun; 19(6):596-602. PubMed ID: 6155359
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation.
    Hu W; Jiang A; Liang J; Meng H; Chang B; Gao H; Qiao X
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):407-15. PubMed ID: 18172119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
    Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.